(2S,3S,4S,5R,6S)-6-((5,6-dihydroxy-4-oxo-2-phenyl-4H-chromen-7-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid hydrate

Catalog No. :
ACZLQC235
CAS No. :
206752-33-2
Molecular Formula :
C21H20O12
Molecular Weight :
464.38

IUPAC Name:(2S,3S,4S,5R,6S)-6-((5,6-dihydroxy-4-oxo-2-phenyl-4H-chromen-7-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid hydrate

(2S,3S,4S,5R,6S)-6-((5,6-dihydroxy-4-oxo-2-phenyl-4H-chromen-7-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid hydrate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2S,3S,4S,5R,6S)-6-((5,6-dihydroxy-4-oxo-2-phenyl-4H-chromen-7-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid hydrate
IUPAC Name(2S,3S,4S,5R,6S)-6-((5,6-dihydroxy-4-oxo-2-phenyl-4H-chromen-7-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid hydrate
MDL No.MFCD00149302
Molecular FormulaC21H20O12
Molecular Weight464.38
SMILESO.O=C(O)[C@H]1O[C@@H](OC2=C(O)C(O)=C3C(=O)C=C(C4=CC=CC=C4)OC3=C2)[C@H](O)[C@@H](O)[C@@H]1O
InChI KeyWLEKZZMZTPAGDD-ZSESPEEFSA-N
SynonymBaicalein 7-O--D-glucuronide | AS-80668 | Baicalin hydrate | (2S,3S,4S,5R,6S)-6-(5,6-dihydroxy-4-oxo-2-phenylchromen-7-yl)oxy-3,4,5-trihydroxyoxane-2-carboxylic acid;hydrate
CAS No.206752-33-2
PubChem CID71311447

Synthetic Route by SureRoute

1. ACZLQC235 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZLQC235 route product structure diagram
    ACZLQC235206752-33-2
Inquiry

2. ACZLQC235 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACVPFJ724 route compound structure diagram
    ACVPFJ72482475-03-4 In Stock
  2. Then
  3. ACZLQC235 route product structure diagram
    ACZLQC235206752-33-2
Inquiry

Comments (0)